Potassium Supplementation in CKD (K+ in CKD)
Renoprotective Effects of Potassium Supplementation in Chronic Kidney Disease (CKD)
Sponsor: Amsterdam UMC
Listed as NCT03253172, this NA trial focuses on Hyperkalemia and Hypertension and remains ongoing. Sponsored by Amsterdam UMC, it has been updated 11 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Jan 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Feb 2022 — Jul 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2021 — Feb 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Sep 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Sep 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC
- Dutch Kidney Foundation
- Erasmus Medical Center
- Leiden University Medical Center
- University Medical Center Groningen
For direct contact, visit the study record on ClinicalTrials.gov .